Discover
RLAY
Relay Therapeutics, Inc.
19.99
27 x 19.98
19 x 19.99
bid
ask
+
0.05
0.25%
1 @ 04:00 PM
20.21 +0.22 (1.10%)
| Ytd | 136.29% | |
| 1y | 515.08% |
19.66
day range
20.26
3.24
52 week range
20.79
| Open | 19.99 | Prev Close | 19.94 | Low | 19.66 | High | 20.26 | Mkt Cap | 4.38B |
| Vol | 0.00 | Avg Vol | 3.92M | EPS | -1.57 | P/E | -12.73 | Forward P/E | -12.32 |
| Beta | 1.70 | Short Ratio | 9.47 | Inst. Own | 92.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 17.70 | 200-d Avg | 11.74 | 1yr Est | 26.38 |
| Income Statement | |||
| Total Revenue | 350.00K | ||
| Revenues (USD) | 350.00K | ||
| Gross Profit | 350.00K | ||
| Operating Expenses | 91.17M | ||
| Research and Development Expense | 76.48M | ||
| Selling, General and Administrative Expense | 14.69M | ||
| Operating Income | -90.82M | ||
| Net Income | -83.71M | ||
| Net Income Common Stock | -83.71M | ||
| Net Income Common Stock (USD) | -83.71M | ||
| Consolidated Income | -83.71M | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -83.71M | ||
| Earning Before Interest & Taxes (USD) | -83.71M | ||
| Weighted Average Shares | 202.85M | ||
| Weighted Average Shares Diluted | 202.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 122.53M | ||
| Cash and Equivalents (USD) | 122.53M | ||
| Investments | 789.75M | ||
| Investments Current | 789.75M | ||
| Current Assets | 928.08M | ||
| Property, Plant & Equipment Net | 38.04M | ||
| Total Assets | 967.46M | ||
| Debt Current | 4.01M | ||
| Total Debt | 30.66M | ||
| Current Liabilities | 50.80M | ||
| Debt Non-Current | 26.64M | ||
| Total Liabilities | 77.45M | ||
| Accumulated Retained Earnings (Deficit) | -2.17B | ||
| Accumulated Other Comprehensive Income | -1.55M | ||
| Shareholders Equity | 890.01M | ||
| Shareholders Equity (USD) | 890.01M | ||
| Assets Non-Current | 39.38M | ||
| Total Debt (USD) | 30.66M | ||
| Liabilities Non-Current | 26.64M | ||
| Trade and Non-Trade Payables | 11.46M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 360.00K | ||
| Net Cash Flow from Financing | 323.74M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -83.40M | ||
| Issuance (Purchase) of Equity Shares | 323.74M | ||
| Net Cash Flow from Investing | -353.03M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -353.03M | ||
| Net Cash Flow from Operations | -54.11M | ||
| Share Based Compensation | 9.18M | ||